Exact Mass: 269.2174796
Exact Mass Matches: 269.2174796
Found 100 metabolites which its exact mass value is equals to given mass value 269.2174796,
within given mass tolerance error 0.05 dalton. Try search metabolite list with more accurate mass tolerance error
0.01 dalton.
Orphenadrine
Orphenadrine is only found in individuals that have used or taken this drug. It is a muscarinic antagonist used to treat drug-induced parkinsonism and to relieve pain from muscle spasm. [PubChem]Orphenadrine binds and inhibits both histamine H1 receptors and NMDA receptors. It restores the motor disturbances induced by neuroleptics, in particular the hyperkinesia. The dopamine deficiency in the striatum increases the stimulating effects of the cholinergic system. This stimulation is counteracted by the anticholinergic effect of orphenadrine. It may have a relaxing effect on skeletal muscle spasms and it has a mood elevating effect. D004791 - Enzyme Inhibitors > D065607 - Cytochrome P-450 Enzyme Inhibitors > D065686 - Cytochrome P-450 CYP2B6 Inhibitors D002491 - Central Nervous System Agents > D018726 - Anti-Dyskinesia Agents > D000978 - Antiparkinson Agents C78272 - Agent Affecting Nervous System > C66880 - Anticholinergic Agent > C29704 - Antimuscarinic Agent D018373 - Peripheral Nervous System Agents > D001337 - Autonomic Agents > D010276 - Parasympatholytics D018377 - Neurotransmitter Agents > D018678 - Cholinergic Agents > D018680 - Cholinergic Antagonists D018373 - Peripheral Nervous System Agents > D009465 - Neuromuscular Agents C78281 - Agent Affecting Musculoskeletal System > C29696 - Muscle Relaxant CONFIDENCE standard compound; EAWAG_UCHEM_ID 3276
pramiracetam
C14H27N3O2 (269.21031619999997)
N - Nervous system > N06 - Psychoanaleptics > N06B - Psychostimulants, agents used for adhd and nootropics C26170 - Protective Agent > C1509 - Neuroprotective Agent
N-[(Ethoxycarbonyl)methyl)-p-menthane-3-carboxamide
N-[(Ethoxycarbonyl)methyl)-p-menthane-3-carboxamide is used as a food additive [EAFUS] ("EAFUS: Everything Added to Food in the United States. [http://www.eafus.com/]")
Bifemelane
D002491 - Central Nervous System Agents > D011619 - Psychotropic Drugs > D000928 - Antidepressive Agents N - Nervous system > N06 - Psychoanaleptics > N06A - Antidepressants C78272 - Agent Affecting Nervous System
N-[(1R)-1-(3-Methoxyphenyl)ethyl]-3-phenylpropan-1-amine
16-oxo-palmitate
16-oxo-palmitate is also known as 16-oxo-hexadecanoate. 16-oxo-palmitate is practically insoluble (in water) and a weakly acidic compound (based on its pKa). 16-oxo-palmitate can be found in a number of food items such as garden rhubarb, japanese pumpkin, carrot, and soy bean, which makes 16-oxo-palmitate a potential biomarker for the consumption of these food products.
Bifemelane
D002491 - Central Nervous System Agents > D011619 - Psychotropic Drugs > D000928 - Antidepressive Agents N - Nervous system > N06 - Psychoanaleptics > N06A - Antidepressants C78272 - Agent Affecting Nervous System
(E,E,E)-2-Methylpropylamide-2,4,12-Tetradecatriene-8,10-diynoic acid|12,13-Didehydro-Anacycline|N-isobutyl-2E,4E,12E-tetradecatrien-8,10-diynamide|Tetradeca-2t,4t,12t-trien-8,10-diinsaeure-isobutylamid|tetradeca-2t,4t,12t-triene-8,10-diynoic acid isobutylamide
(+/-)-threo-1-(1-oxo-4,5-dihydroxy-2E-decaenyl)piperidine
(E)-3-(3-Hydroxymethyl-2-butenyl)-7-(3-methyl-2-butenyl)-1H-indole
2-pentyl-1,5,9-triazacyclotridecan-4-one|equisetumine
Pyrrolidide-2,4-Tetradecadiene-8,10-diynoic acid|tetradeca-2E,4E-dien-8,10-diynoic acid pyrrolidide
SPI_270.2429_14.9
CONFIDENCE Probable structure via diagnostic evidence, tentative identification (Level 2b); INTERNAL_ID 1810
(2S,5S)-5-((E)-pent-2-en-4-yn-1-yl)-2-(penta-3,4-dien-1-yl)decahydroquinoline
(2S,5R)-5-((E)-pent-2-en-4-yn-1-yl)-2-(penta-3,4-dien-1-yl)decahydroquinoline
(2S,5S,8aS)-5-((E)-pent-2-en-4-yn-1-yl)-2-(penta-3,4-dien-1-yl)decahydroquinoline
(2R,5R)-2-((E)-pent-2-en-4-yn-1-yl)-5-(penta-3,4-dien-1-yl)decahydroquinoline
(2S,5R)-5-((E)-pent-2-en-4-yn-1-yl)-2-(pent-4-yn-1-yl)decahydroquinoline
(5R,8R)-8-(but-3-en-1-yl)-5-((E)-hept-4-en-6-yn-1-yl)-1,2,3,5,8,8a-hexahydroindolizine
N-[(Ethoxycarbonyl)methyl)-p-menthane-3-carboxamide
1-N-BOC 3-(PIPERIDIN-4-YLAMINO) PYRROLIDINE
C14H27N3O2 (269.21031619999997)
TERT-BUTYL 4-(3-AMINOPYRROLIDIN-1-YL)PIPERIDINE-1-CARBOXYLATE
C14H27N3O2 (269.21031619999997)
tert-butyl 1,1-dimethyl-2-oxa-8-azaspiro[4.5]decane-8-carboxylate
N,N-dimethyl-2-[(4-methylphenyl)-phenylmethoxy]ethanamine
(8r,9s,13s,14s)-3-amino-13-methyl-6,7,8,9,11,12,13,14,15,16-decahydro-cyclopenta[a]phenanthren-17-one
(S,S)-3,4-trans-(N-Boc)-diaminopyrrolidine
C14H27N3O2 (269.21031619999997)
Ethyl N-[[5-methyl-2-(isopropyl)cyclohexyl]carbonyl]glycinate
tert-Butyl 4-piperazinotetrahydro-1(2H)-pyridinecarboxylate
C14H27N3O2 (269.21031619999997)
tert-butyl 4-[3-(aminomethyl)azetidin-1-yl]piperidine-1-carboxylate
C14H27N3O2 (269.21031619999997)
3-(4-amino-piperidin-1-yl)-pyrrolidine-1-carboxylic acid tert-butyl ester
C14H27N3O2 (269.21031619999997)
TERT-BUTYL ((S)-2-CYCLOHEXYL-1-((S)-OXIRAN-2-YL)ETHYL)CARBAMATE
(S)-(-)-2,2-BIS(DI-P-TOLYLPHOSPHINO)-1,1-BINAPHTHYL
tert-butyl 9-hydroxy-3-azaspiro[5.5]undecane-3-carboxylate
(1-PIPERIDIN-4-YL-PYRROLIDIN-3-YL)-CARBAMICACIDTERT-BUTYLESTER
C14H27N3O2 (269.21031619999997)
(7-CHLOROTHIAZOLO[5,4-D]PYRIMIDIN-2-YL)-PYRIDIN-3-YL-AMINE
C14H27N3O2 (269.21031619999997)
tert-butyl N-[(1-piperidin-4-ylazetidin-3-yl)methyl]carbamate
C14H27N3O2 (269.21031619999997)
TERT-BUTYL 4-(PIPERIDIN-4-YL)PIPERAZINE-1-CARBOXYLATE
C14H27N3O2 (269.21031619999997)
(1-PHENYL-1H-PYRAZOLO[3,4-D]PYRIMIDIN-4-YL)-HYDRAZINE
C14H27N3O2 (269.21031619999997)
tert-Butyl ((1-(piperidin-3-yl)azetidin-3-yl)methyl)carbamate
C14H27N3O2 (269.21031619999997)
tert-butyl 3-[3-(aminomethyl)azetidin-1-yl]piperidine-1-carboxylate
C14H27N3O2 (269.21031619999997)
Heptanoic acid (2,2,6,6-tetramethyl-4-piperidinyl) ester
nAChR-IN-1 (2,2,6,6-Tetramethylpiperidin-4-yl heptanoate) is a tetramethylpiperidine heptanoate, a selective nicotinic acetylcholine receptor (nAChR) inhibitor that inhibits nAChRs lacking α5, α6, or β3 subunits. nAChR-IN-1 has the effect of preventing nerve disorder, can be used for nicotinic acetylcholine receptor dysfunction or neurological disorders research[1].
Margarate
A straight-chain saturated fatty acid anion that is the conjugate base of margaric acid, obtained by deprotonation of the carboxy group.
2-Methylhexadecanoate
A 2-methyl fatty acid anion that is the conjugate base of 2-methylhexadecanoic acid, obtained by deprotonation of the carboxy group; major species at pH 7.3.
N-(4-ethylphenyl)bicyclo[6.1.0]non-2-ene-9-carboxamide
1,2,3-Trimethyl-5-trimethylsilyloxy-2-azabicyclo[4.4.0]decane
N-[(4E,8E)-1,3-dihydroxydodeca-4,8-dien-2-yl]propanamide
N-[(4E,8E)-1,3-dihydroxytrideca-4,8-dien-2-yl]acetamide
orphenadrine
D004791 - Enzyme Inhibitors > D065607 - Cytochrome P-450 Enzyme Inhibitors > D065686 - Cytochrome P-450 CYP2B6 Inhibitors D002491 - Central Nervous System Agents > D018726 - Anti-Dyskinesia Agents > D000978 - Antiparkinson Agents C78272 - Agent Affecting Nervous System > C66880 - Anticholinergic Agent > C29704 - Antimuscarinic Agent D018373 - Peripheral Nervous System Agents > D001337 - Autonomic Agents > D010276 - Parasympatholytics D018377 - Neurotransmitter Agents > D018678 - Cholinergic Agents > D018680 - Cholinergic Antagonists D018373 - Peripheral Nervous System Agents > D009465 - Neuromuscular Agents C78281 - Agent Affecting Musculoskeletal System > C29696 - Muscle Relaxant
16-oxohexadecanoate
An omega-oxo fatty acid anion that is the conjugate base of 16-oxohexadecanoic acid, arising from the deprotonation of the carboxy group; major species at pH 7.3.
Isoheptadecanoate
A methyl-branched fatty acid anion that is the conjugate base of isoheptadecanoic acid, obtained by deprotonation of the carboxy group; major species at pH 7.3.
fatty acid anion 17:0
Any saturated fatty acid anion containing 17 carbons. Formed by deprotonation of the carboxylic acid moiety. Major species at pH 7.3.